Published in Am J Med Sci on September 01, 1965
Pneumococcal resistance to antibiotics. Clin Microbiol Rev (1990) 9.76
Detection and prevalence of pneumococci with increased resistance to penicillin. Can Med Assoc J (1977) 2.73
Genetic relationships of penicillin-susceptible and -resistant Streptococcus pneumoniae strains isolated on different continents. Infect Immun (1992) 2.62
Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother (1992) 2.60
Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev (2011) 1.66
Antimicrobial susceptibility of Streptococcus pneumoniae: serotype distribution of penicillin-resistant strains in Spain. Antimicrob Agents Chemother (1982) 1.56
Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents. Antimicrob Agents Chemother (1976) 1.49
Penicillin-resistant variants of pneumococci. Appl Microbiol (1968) 1.40
Tetracycline levels in bronchial secretions. J Clin Pathol (1970) 1.06
The multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success. Genome Biol (2012) 1.01
Novel type of Streptococcus pneumoniae causing multidrug-resistant acute otitis media in children. Emerg Infect Dis (2009) 0.96
Reporting Emerging Resistance of Streptococcus pneumoniae from India. J Glob Infect Dis (2010) 0.96
Incidence of decreased penicillin sensitivity of Streptococcus pneumoniae from clinical isolates. J Clin Pathol (1988) 0.95
Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones. J Clin Microbiol (2005) 0.90
Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective. Clin Microbiol Rev (2016) 0.82
Emergence of a unique penicillin-resistant Streptococcus pneumoniae serogroup 35 strain. J Clin Microbiol (2010) 0.79
Antibiotic resistant Streptococcus pneumoniae. Thorax (1996) 0.76
The Ongoing Genetic Adaptation of Streptococcus pneumoniae. J Clin Microbiol (2016) 0.75
Seroepidemiologic characterization of Streptococcus pneumoniae in a Saudi hospital. J Natl Med Assoc (1987) 0.75
Incidence of bacterial respiratory pathogens and their susceptibility to common antibacterial agents. J Natl Med Assoc (1993) 0.75
Antimicrobial resistance in Streptococcus pneumoniae: a growing universal concern. J Natl Med Assoc (1989) 0.75
Tetracycline resistance in pneumococci and group A streptococci. Report of an ad-hoc study group on antibiotic resistance. Br Med J (1977) 0.75
Penicillin-resistaant pneumococci. Br Med J (1971) 0.75
ANTIBODY RESPONSE TO INFECTIONS WITH THE NEWLY CLASSIFIED TYPES OF PNEUMOCOCCI (COOPER). J Clin Invest (1934) 10.11
Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci (1969) 10.08
STUDIES ON THE ACTION OF SULFAPYRIDINE ON PNEUMOCOCCI. J Clin Invest (1940) 9.39
COLD AGGLUTININS (AUTOHEMAGGLUTININS) IN PRIMARY ATYPICAL PNEUMONIAS. Science (1943) 9.20
Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma. J Lab Clin Med (1971) 8.13
OBSERVATIONS ON THE INHIBITION OF SULFONAMIDE ACTION BY PARA-AMINOBENZOIC ACID. J Clin Invest (1941) 8.03
Changing ecology of bacterial infections as related to antibacterial therapy. J Infect Dis (1970) 7.72
Observations on Bacteria Sensitive to, Resistant to, and Dependent upon Streptomycin. J Bacteriol (1948) 7.56
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet (1999) 7.39
Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrob Agents Chemother (1975) 6.82
The susceptibility of Bacteroides fragilis to 24 antibiotics. J Infect Dis (1972) 6.12
Bacteriologic Studies on Aureomycin. J Bacteriol (1948) 5.91
A COMPARATIVE STUDY OF THE BLOOD CONCENTRATIONS AND URINARY EXCRETION OF SULFAPYRIDINE AND SULFANILAMIDE AFTER SINGLE DOSES OF SULFAPYRIDINE AND RELATED COMPOUNDS ADMINISTERED BY VARIOUS ROUTES. J Clin Invest (1940) 5.45
BACTERICIDAL ACTION OF SODIUM SULFAPYRIDINE AND OF A GLUCOSE-SULFAPYRIDINE SOLUTION IN HUMAN BLOOD. J Clin Invest (1940) 4.89
THE INFLUENCE OF DOSAGE AND ROUTE OF INJECTION ON THE ANTIBODY RESPONSE OF HUMAN SUBJECTS TO THE SPECIFIC CARBOHYDRATE OF THE TYPE VIII PNEUMOCOCCUS. J Clin Invest (1935) 4.41
Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med (1968) 4.38
Microassay for human and chick cell interferons. Appl Microbiol (1968) 4.20
Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Am J Med Sci (1968) 4.00
Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci (1968) 3.78
Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrob Agents Chemother (1976) 3.59
Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol (1977) 3.37
Pathology of Staphylococcal Pneumonia Complicating Clinical Influenza. Am J Pathol (1943) 3.28
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci (1967) 3.17
PNEUMOCOCCIC INFECTIONS IN FAMILIES. J Clin Invest (1936) 3.14
Bacteroides fragilis resistant to the administration of clindamycin. Am J Med (1976) 3.13
The Klebsiella-Enterobacter-Serratia division. Biochemical and serologic characteristics and susceptibility to antibiotics. Ann Intern Med (1966) 3.07
Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother (1973) 3.05
The Klebsiella-Enterobacter-Serratia division. Clinical and epidemiologic characteristics. Ann Intern Med (1966) 2.92
Pathologic Findings in the Lungs of Five Cases from Which Influenza Virus Was Isolated. Am J Pathol (1946) 2.91
Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol (1970) 2.83
Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. J Infect Dis (1969) 2.80
Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. J Infect Dis (1975) 2.78
Rapid microassay for circulating nephrotoxic antibiotics. Antimicrob Agents Chemother (Bethesda) (1970) 2.73
Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype. Br J Psychiatry (1997) 2.71
Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria. Appl Microbiol (1968) 2.55
Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53
Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther (2011) 2.50
Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization. J Lab Clin Med (1968) 2.45
OBSERVATIONS ON THE URINARY EXCRETION OF SULFADIAZINE. J Clin Invest (1943) 2.44
Use of gentamicin in combinations with other antibiotics. J Infect Dis (1969) 2.37
AGGLUTININS FOR HUMAN ERYTHROCYTES IN TYPE XIV ANTI-PNEUMOCOCCIC HORSE SERUMS. Science (1938) 2.23
Streptomycin-sensitive, -dependent, and -resistant Bacteria. Science (1948) 2.23
Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972. Am J Med (1974) 2.13
The pharmacogenetics of chemical carcinogenesis. Pharmacogenetics (1992) 2.12
Infections and antibiotic use among patients at Boston City Hospital, February, 1967. N Engl J Med (1968) 2.12
Cephaloridine activity in vitro and absorption and urinary excretion in normal young men. Am J Med Sci (1966) 2.09
Thiol-group binding of zinc to a beta-lactamase of Bacillus cereus: differential effects on enzyme activity with penicillin and cephalosporins as substrates. J Bacteriol (1968) 2.08
Carbenicillin: activity in vitro and absorption and excretion in normal young men. Appl Microbiol (1968) 2.07
Changing etiology of bacterial endocarditis in the antibacterial era. Experiences at Boston City Hospital 1933-1965. Ann Intern Med (1970) 2.06
THE NEW PENICILINS. N Engl J Med (1963) 2.02
Lincomycin: activity in vitro and absorption and excretion in normal young men. Am J Med Sci (1967) 2.00
Colonization of newborn infants by mycoplasmas. N Engl J Med (1969) 1.98
Pulmonary nocardiosis. Therapy with minocycline and with erythromycin plus ampicillin. JAMA (1973) 1.94
Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology (1997) 1.94
Bacteremia in febrile children seen in a "walk-in" pediatric clinic. N Engl J Med (1973) 1.92
Activity of minocycline against Nocardia asteroides: comparison with tetracycline in agar-dilution and standard disc-diffusion tests and with sulfadiazine in an experimental infection of mice. J Lab Clin Med (1973) 1.90
Resistance of penicillins and cephalosporins to beta-lactamases from Gram-negative bacilli: some correlations with antibacterial activity. Ann N Y Acad Sci (1967) 1.88
Acute otitis media in children. Serologic studies and attempts to isolate viruses and mycoplasmas from aspirated middle-ear fluids. N Engl J Med (1967) 1.87
Usage of antibiotics in a general hospital: effect of requiring justification. J Infect Dis (1974) 1.86
Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology (1998) 1.84
Infection and antibiotic usage at Boston City Hospital: changes in prevalence during the decade 1964-1973. J Infect Dis (1974) 1.83
Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents. Ann Intern Med (1972) 1.83
Effect of pH of medium and size of inoculum on activity of antibiotics against group D Streptococcus (Enterococcus). Appl Microbiol (1970) 1.78
Absorption and excretion of five tetracycline analogues in normal young men. Am J Med Sci (1968) 1.72
Pneumococcal bacteremia. Review of 111 cases, 1957--1969, with special reference to cases with undetermined focus. Am J Dis Child (1971) 1.71
Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet (1999) 1.68
Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut (2000) 1.68
Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents. Antimicrob Agents Chemother (1976) 1.65
Independent segregation of chloramphenicol resistance in Staphylococcus aureus. Antimicrob Agents Chemother (Bethesda) (1967) 1.63
The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol Sci (1992) 1.61
Clinical evaluation of cephaloridine. Arch Intern Med (1968) 1.59
Cephalexin and cephaloglycin activity in vitro and absorption and urinary excretion of single oral doses in normal young adults. Appl Microbiol (1968) 1.56
Infection and antibiotic usage at Boston City Hospital, January 1970. Arch Intern Med (1971) 1.55
Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection. J Exp Med (1969) 1.53
Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents. Arch Intern Med (1970) 1.50
Klebsiella-Enterobacter at Boston City Hospital, 1967. Arch Intern Med (1970) 1.50
Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis (1997) 1.49
Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents. Antimicrob Agents Chemother (1976) 1.49
Isolation of Eikenella corrodens in a general hospital. Appl Microbiol (1973) 1.48
Synergistic penicillin combinations for treatment of human urinary-tract infections. Antimicrob Agents Chemother (Bethesda) (1966) 1.48
Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Res (1995) 1.46
Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species. Antimicrob Agents Chemother (1976) 1.43
White paper on the therapeutic equivalence of chemically equivalent drugs. JAMA (1969) 1.43
CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst (1997) 1.43
In vitro activity of cefazolin against recent clinical bacterial isolates. J Infect Dis (1973) 1.42
Effect of intranasal reovirus infection on antibacterial activity of mouse lung. J Infect Dis (1969) 1.41
Erythromycin plus alkalinization in treatment of urinary infections. Antimicrob Agents Chemother (Bethesda) (1969) 1.40
Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics (1995) 1.39
Altered cell walls of Staphylococcus aureus resistant to methicillin. Nature (1970) 1.39
Meningitis and bacteremia due to Haemophilus influenzae: occurrence and mortality at Boston City Hospital in 12 selected years, 1935-1972. J Infect Dis (1974) 1.39
Type 6 pneumococcus resistant to erythromycin and lincomycin. N Engl J Med (1967) 1.38
Increasing the usefulness of antibiotics: Treatment of infections caused by gram-negative bacilli. Clin Pharmacol Ther (1970) 1.38
Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet (1992) 1.38
Microbiological investigation of Bartholin's gland abscesses and cysts. Am J Obstet Gynecol (1977) 1.35
Proteus mirabilis infections in a hospital nursery traced to a human carrier. N Engl J Med (1971) 1.30
The treatment of endocarditis. Am Heart J (1970) 1.29